PINK:ALPMY

ASTELLAS PHARMA INC Stock Predictions

Pink Sheets > Healthcare > Drug Manufacturers—General

Open Broker Account

$9.63

+0.0800 (+0.84%)

At Close: Apr 29, 2024

Currently predicting for Wed, 1 May 2024

Trading levels for ALPMY

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	9.75	1.25 %
		R2	9.70	0.770 %
		R1	9.68	0.476 %
Current price:			9.63
	Support	S1	9.58	-0.476 %
		S2	9.56	-0.770 %
		S3	9.51	-1.25 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	11.00	14.23 %
		R2	10.89	13.08 %
		R1	10.75	11.63 %
Current price			9.63
	Support	S1	9.55	-0.83%
		S2	9.50	-1.35%
		S3	9.47	-1.66%

ALPMY Predictions History

5 years ago
NameNotImportant predicted that ALPMY for 2019-04-24 is going $13.78 (1.66%)

About ASTELLAS PHARMA INC

Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a ... ALPMY Profile

Golden Star

Ticker	Date	Change	Price
DHT	Apr 24	1.95%	$11.28
MLI	Apr 19	11.07%	$52.28
LPLA	Apr 19	4.31%	$262.59
DOOR	Apr 18	0.90%	$131.39
PFLT	Apr 18	1.78%	$11.25
LNG	Apr 17	3.12%	$156.81
FCN	Apr 16	2.83%	$207.62
ELV	Apr 16	5.33%	$506.97
AKR	Apr 05	6.47%	$16.53
ITCI	Apr 05	5.64%	$68.44

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In